A recent opinion crossed our desk: Independence County v. Pfizer, Inc., ___ F. Supp.2d ___, 2008 WL 398980 (E.D. Ark. Feb. 11, 2008). The opinion has generated a bit of interest because of the unusual nature of the claim – which is, we suppose, to be expected where, as here, a local government has
Search results for: nuisance
More Federal Officer Jurisdiction and PBMs – Second Circuit Finds Jurisdiction
Federal officer jurisdiction is having a moment. In November 2024, we called federal officer jurisdiction the quiet middle child of the federal jurisdiction family, but then earlier this year the Supreme Court decided Chevron USA Inc. v. Plaquemines Parish. That opinion held that federal officer jurisdiction was broader than many previously thought, which we…
The Continuing Demise of Market Share Liability
We published a 50-state survey on the widespread rejection of so-called market share liability back 2010, which we recently referenced in our post celebrating the demise of an “ultra processed” food strike suit in Pennsylvania. As that post discussed, one of the liability theories that failed was market share liability. That got us thinking that…
Preemption Is a Defense, Not a Basis for Jurisdiction
If preemption were an independent basis for federal subject matter jurisdiction, almost all of our drug, device, and vaccine product liability litigation would be in federal court. We’ve long been resigned that preemption is a defense, not grounds for jurisdiction. E.g., Merrell Dow Pharmaceuticals, Inc. v. Thompson, 478 U.S. 804, 811 (1986). A…
A Big Idea from Big Sky Country
…[T]he common law of public nuisance is an inapt vehicle for addressing the conduct at issue. Mass harms caused by
Update on the New 4th Edition of the Reference Manual on Scientific Evidence
Last month we were one of the first on the web with a review of the new Reference Manual on Scientific Evidence, Fourth Edition. Since it was nearly 1700 pages long – literally longer than “War & Peace” – we did only the most cursory of analyses, describing differences in topics and authors…
Digital Health Liability Law In Flux
Not quite three years ago, we co-authored a chapter in a Digital Health guide put out by International Comparative Legal Guides. It bore the pithy title “Predicting Risk and Examining the Intersection of Traditional Principles of Product Liability Laws with Digital Health.” We continue to tinker with the principles of product liability law…
Running the Table – The Ten Best Prescription Drug/Medical Device Decisions of 2025
A year ago, Bexis thought this would be the last blogpost he would ever write, and that he would retire along with 2025. Not gonna happen – at least not yet, thanks to Reed Smith making him an offer he couldn’t refuse. Bexis will be stepping back from some things, but not from the Blog. …
Running on Empty -The Ten Worst Prescription Drug/Medical Device Decisions Of 2025
It’s time for our annual parade of horribles. It’s no fun, but somebody needs to do it, if only to make sure that the other side, and those who aid and abet them, know that we are paying attention. So here is our annual naughty list, the bottom ten worst prescription medical product liability litigation…
Fen-Phen Flashback
It feels like 20 years ago when we were doing almost monthly fen-phen diet drug trials in the Philadelphia Court of Common Pleas. The old timey-air-conditioning units in City Hall, along with subways rumbling underfoot, occasionally drowned out the testimony of plaintiff experts taking both scientific studies and internal company documents out of context. That…